跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Hepcidin
首页
药物
Hepcidin
Hepcidin
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
USE OF BMP ANTAGONISTS TO REGULATE HEPCIDIN-MEDIATED IRON METABOLISM
EP 2954903 A1
申请人: GEN HOSPITAL CORP
优先权: 2005
EP
US
11 件公开
Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids
US 7411048 B2
申请人: DRG INTERNATIONAL INC
优先权: 2002
US
10 件公开
CONJUGATED HEPCIDIN MIMETICS
EP 4188412 A4
申请人: PROTAGONIST THERAPEUTICS INC
优先权: 2020
EP
US
WO
8 件公开
EP 4706671 A3
申请人: PROTAGONIST THERAPEUTICS INC
优先权: 2019
CN
EP
US
WO
6 件公开
EP 4501952 A3
申请人: PROTAGONIST THERAPEUTICS INC
优先权: 2018
EP
US
4 件公开
EP 4314014 A4
申请人: PROTAGONIST THERAPEUTICS INC
优先权: 2021
EP
US
WO
3 件公开
CN 116457000 A
申请人: PROTAGNEST THERAPEUTICS INC
优先权: 2021
CN
2 件公开
US 20250277012 A1
申请人: PROTAGONIST THERAPEUTICS INC
优先权: 2022
US
US 20250170216 A1
申请人: PROTAGONIST THERAPEUTICS INC
优先权: 2023
US
US 20250361280 A1
申请人: PROTAGONIST THERAPEUTICS INC
优先权: 2023
US
Use of hepcidin as a regulator of iron homeostasis
US 7169758 B2
申请人: INST NAT SANTE RECH MED
优先权: 2001
CN
US
8 件公开
HEPCIDIN ANALOGUES AND USES THEREOF
EP 4091624 A1
申请人: PROTAGONIST THERAPEUTICS INC
优先权: 2013
EP
US
8 件公开
Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
US 7749713 B2
申请人: KULAKSIZ HASAN
优先权: 2003
US
6 件公开
Methods for measuring levels of bioactive human hepcidin
US 7723063 B2
申请人: INTRINSIC LIFESCIENCES
优先权: 2005
US
6 件公开
Anti-hepcidin antibodies and uses thereof
US 7820163 B2
申请人: LILLY CO ELI
优先权: 2008
US
6 件公开
US 9657098 B2
申请人: INTRINSIC LIFESCIENCES LLC
优先权: 2014
US
3 件公开
Modified mini-hepcidin peptides and methods of using thereof
US 9328140 B2
申请人: UNIV CALIFORNIA
优先权: 2011
CN
US
WO
5 件公开
Competitive regulation of hepcidin mRNA by soluble and cell-associated hemojuvelin
US 7534764 B2
申请人: UNIV CALIFORNIA
优先权: 2006
US
5 件公开
第 1 / 9 页
上一页
下一页
药物
反馈